Prediction of noncovalent interactions for PDB structure 5LBG
=============================================================
Created on 2023/09/02 using PLIP v2.2.2

If you are using PLIP in your work, please cite:
Adasme,M. et al. PLIP 2021: expanding the scope of the protein-ligand interaction profiler to DNA and RNA. Nucl. Acids Res. (05 May 2021), gkab294. doi: 10.1093/nar/gkab294
Analysis was done on model 1.

3HL:B:501 (3HL) - SMALLMOLECULE
-------------------------------
Interacting chain(s): B


**Hydrophobic Interactions**
+-------+---------+----------+-----------+-------------+--------------+------+--------------+---------------+------------------------+------------------------+
| RESNR | RESTYPE | RESCHAIN | RESNR_LIG | RESTYPE_LIG | RESCHAIN_LIG | DIST | LIGCARBONIDX | PROTCARBONIDX | LIGCOO                 | PROTCOO                | 
+=======+=========+==========+===========+=============+==============+======+==============+===============+========================+========================+
| 318   | TYR     | B        | 501       | 3HL         | B            | 3.97 | 8188         | 6783          | 28.219, 9.517, -17.390 | 31.823, 9.836, -15.747 | 
+-------+---------+----------+-----------+-------------+--------------+------+--------------+---------------+------------------------+------------------------+
| 333   | VAL     | B        | 501       | 3HL         | B            | 3.62 | 8191         | 7013          | 27.676, 7.314, -18.661 | 24.757, 5.298, -19.369 | 
+-------+---------+----------+-----------+-------------+--------------+------+--------------+---------------+------------------------+------------------------+


**Hydrogen Bonds**
+-------+---------+----------+-----------+-------------+--------------+-----------+----------+----------+-----------+-----------+----------+-----------+-------------+--------------+-------------------------+-------------------------+
| RESNR | RESTYPE | RESCHAIN | RESNR_LIG | RESTYPE_LIG | RESCHAIN_LIG | SIDECHAIN | DIST_H-A | DIST_D-A | DON_ANGLE | PROTISDON | DONORIDX | DONORTYPE | ACCEPTORIDX | ACCEPTORTYPE | LIGCOO                  | PROTCOO                 | 
+=======+=========+==========+===========+=============+==============+===========+==========+==========+===========+===========+==========+===========+=============+==============+=========================+=========================+
| 318   | TYR     | B        | 501       | 3HL         | B            | True      | 1.98     | 2.81     | 146.35    | True      | 6785     | O3        | 8190        | O3           | 29.128, 7.346, -16.817  | 29.967, 8.845, -14.587  | 
+-------+---------+----------+-----------+-------------+--------------+-----------+----------+----------+-----------+-----------+----------+-----------+-------------+--------------+-------------------------+-------------------------+
| 332   | GLY     | B        | 501       | 3HL         | B            | False     | 2.99     | 3.76     | 138.95    | False     | 8190     | O3        | 7003        | O2           | 29.128, 7.346, -16.817  | 25.609, 8.066, -15.705  | 
+-------+---------+----------+-----------+-------------+--------------+-----------+----------+----------+-----------+-----------+----------+-----------+-------------+--------------+-------------------------+-------------------------+
| 352   | HIS     | B        | 501       | 3HL         | B            | False     | 2.80     | 3.48     | 124.71    | True      | 7273     | Nam       | 8193        | O2           | 28.433, 10.875, -19.365 | 30.921, 11.177, -21.777 | 
+-------+---------+----------+-----------+-------------+--------------+-----------+----------+----------+-----------+-----------+----------+-----------+-------------+--------------+-------------------------+-------------------------+
| 354   | CYS     | B        | 501       | 3HL         | B            | False     | 2.18     | 2.97     | 134.35    | True      | 7297     | Nam       | 8193        | O2           | 28.433, 10.875, -19.365 | 26.652, 9.842, -21.508  | 
+-------+---------+----------+-----------+-------------+--------------+-----------+----------+----------+-----------+-----------+----------+-----------+-------------+--------------+-------------------------+-------------------------+



